PRQR Competitors & Alternatives
Compare ProQR Therapeutics BV with similar stocks in the same industry
Biotechnology
PRQR
Main Stock$1.33
Tradestie Score
64
Market Cap
$227.54M
Revenue Growth
1.2%
Analyst Upside
+484.8%
Top Competitors
220 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NGNE
Neurogene, Inc. Common Stock
|
$25.65
|
$256.54M | - | 35 | Compare |
|
SLN
Silence Therapeutics Plc American Depository Share
|
$19.72
|
$240.89M | - | 35 | Compare |
|
OABI
OmniAb, Inc. Common Stock
|
$4.83
|
$231.77M | - | 40 | Compare |
|
SGMT
Sagimet Biosciences Inc. Series A Common Stock
|
$9.12
|
$227.00M | - | 42 | Compare |
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$7.88
|
$211.22M | - | 47 | Compare |
|
ACRS
Aclaris Therapeutics, Inc.
|
$3.61
|
$202.58M | - | 46 | Compare |
|
CBIO
Crescent Biopharma, Inc. Common Stock
|
$12.94
|
$199.71M | - | 55 | Compare |
|
FBRX
Forte Biosciences, Inc. Common Stock
|
$76.99
|
$180.53M | - | 54 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$6.38
|
$158.43M | - | 53 | Compare |
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$17.76
|
$154.27M | - | 46 | Compare |
More PRQR Analysis
Data updated: Nov 06, 2026 | Industry: Biotechnology (SIC 2834)
220 stocks in this industry